Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs RPRX✓SelectedUSD · RPRXGSK vs RPRX performance historyLatest closeAs of+0.52%11/13
Stock and ETF performance explorer

GSK vs RPRX

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+61.5%
RPRX return
+81.2%
Excess return
-19.7%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioRPRXExcessAlpha
1D+0.5%+0.8%-0.3%+0.3%
7D+1.1%+3.3%-2.2%+0.4%
30D+6.3%+17.9%-11.6%+2.4%
3M+1.8%+19.2%-17.4%-2.2%
6M+1.7%+31.7%-30.1%-4.5%
YTD+6.5%+82.5%-75.9%-6.2%
1Y+9.5%+78.4%-69.0%-3.2%
3Y+65.3%+177.0%-111.6%+34.5%
5Y+43.7%+86.5%-42.7%+23.5%
All+61.5%+81.2%-19.7%+36.7%

Cumulative growth

Daily Returns

Daily percentage return beside RPRX.

Daily Out/Under-Performance

Portfolio return minus RPRX return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × RPRX return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded RPRX wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling